Skip to main content
TipRanks
Go Ultimate75% OFF

John Canepa Insider Profile

4 Followers

John Canepa, CFO at Candel Therapeutics, holds 10.13K shares in Candel Therapeutics (Ticker: CADL), holds 1.77K shares in Harvard Apparatus Regenerative Technology (Ticker: HRGN). Most recently, John Canepa Bought ― shares of Candel Therapeutics on Aug 02, 2021 for an estimated value of $81.00K.

John Canepa's Trading History

CADL
Candel Therapeutics
Aug 02, 2021CFOInformative Buy81.00K$62.77K
HRGN
Harvard Apparatus Regenerative Technology
Mar 28, 2018DirectorUninformative Buy2.94K$3.50K

You May Also Like

John Canepa insider profile FAQ

What is the percentage of profitable transactions made by John Canepa?
The percentage of profitable transactions made by John Canepa is 0%.
What is the average return per transaction made by John Canepa?
The average return per transaction made by John Canepa is -68.60%.
What stocks does John Canepa hold?
John Canepa holds: CADL, HRGN stocks.
What was John Canepa’s latest transaction?
John Canepa’s latest transaction was an Informative Buy of $81.00K.
What was John Canepa's most profitable transaction?
John Canepa’s most profitable transaction was an Informative Buy of CADL stock on August 2, 2021. The return on the trade was -56.00%.
What is John Canepa's role in Candel Therapeutics?
John Canepa's role in Candel Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.